Damora Therapeutics, Inc. (DMRA)

Healthcare · Biotechnology · NASDAQ

Damora Therapeutics, Inc. (DMRA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.84B and a free-cash-flow yield of -16.5%.

Market cap	$1.84B
Trailing P/E	—
FCF yield	-16.5%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live DMRA data on Nama Insights →